Delphi advisor to Olink Holding AB (publ) in the USD 116 million offering of American Depositary Shares (ADSs)

Advokatfirman Delphi has advised Olink Holding AB (publ) in the USD 116 million offering of American Depositary Shares (ADSs). Each ADS represents one share in the company and the ADSs in the offering consisted of both newly issued shares and existing shares sold by certain shareholders of the company.

Olink (Nasdaq US: OLK) is a company dedicated to accelerating proteomics together with the scientific community, across multiple disease areas to enable new discoveries and improve the lives of patients. Olink provides a platform of products and services which are deployed across major biopharmaceutical companies and leading clinical and academic institutions to deepen the understanding of real-time human biology and drive 21st century healthcare through actionable and impactful science.

Delphi’s team consisted of Annika Melin Jakobsson, Andreas Wirén, Emil Apelman and Alexander Nilsson.